CYTOMX THERAPEUTICS, INC.
Patent Owner
Stats
- 26 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 26 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,220 Total Citation Count
- Oct 09, 2001 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0072,067 COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIESNov 22, 16Mar 16, 17[A61K, C07K]
2017/0002,082 ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS OF USE THEREOFSep 21, 16Jan 05, 17[C07K]
2016/0264,961 PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOFMar 28, 16Sep 15, 16[C12N, C07K]
2016/0194,399 ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC ANTI-CD3 ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAMEJul 24, 15Jul 07, 16[A61K, C07K]
2015/0087,810 Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use ThereofSep 25, 14Mar 26, 15[C07K]
2015/0079,088 MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAMEJul 25, 14Mar 19, 15[C07K]
2014/0023,664 Activatable Antibodies Having Non-Binding Steric Moieties and Methods of Using the SameJun 21, 13Jan 23, 14[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9889211 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofDec 16, 16Feb 13, 18[A61K, G01N]
9856314 Activatable antibodies having non-binding steric moieties and methods of using the sameJun 21, 13Jan 02, 18[A61K, G01N, C07K]
9737623 Antibodies that bind activatable antibodies and methods of use thereofDec 11, 14Aug 22, 17[A61K, G01N, C07K]
9695249 Antibodies specific for urokinase-type plasminogen activator and methods of use thereofDec 17, 15Jul 04, 17[A61K, C07K]
9688748 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofJul 31, 15Jun 27, 17[A61K, C12P, C07K]
9644016 Soluble notch receptor proproteins and methods of use thereofMar 30, 15May 09, 17[A61K, G01N, C07K]
9562073 Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofJan 30, 15Feb 07, 17[A61K, C07K]
9545442 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofJul 31, 15Jan 17, 17[A61K, C12P, G01N, C07K]
9540440 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofOct 30, 14Jan 10, 17[A61K, G01N, C07K]
9517276 Compositions and methods for conjugating activatable antibodiesJun 04, 14Dec 13, 16[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0309,230 Modified Antibody Compositions, Methods of Making and Using ThereofAbandonedMar 04, 13Nov 21, 13[C07K]
2010/0189,651 MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOFAbandonedJan 12, 10Jul 29, 10[A61K, A61P, C07K]
2009/0304,719 ACTIVATABLE BINDING POLYPEPTIDES AND METHODS OF IDENTIFICATION AND USE THEREOFAbandonedAug 21, 08Dec 10, 09[A61K, C12P, C12N, G01N, C40B, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
